241 related articles for article (PubMed ID: 30775158)
1. Molecular Mechanisms of Transcription Factor 4 in Pitt Hopkins Syndrome.
Rannals MD; Maher BJ
Curr Genet Med Rep; 2017 Mar; 5(1):1-7. PubMed ID: 30775158
[TBL] [Abstract][Full Text] [Related]
2. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects.
Sepp M; Pruunsild P; Timmusk T
Hum Mol Genet; 2012 Jul; 21(13):2873-88. PubMed ID: 22460224
[TBL] [Abstract][Full Text] [Related]
3. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.
Thaxton C; Kloth AD; Clark EP; Moy SS; Chitwood RA; Philpot BD
J Neurosci; 2018 Jan; 38(4):918-936. PubMed ID: 29222403
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome.
Rannals MD; Page SC; Campbell MN; Gallo RA; Mayfield B; Maher BJ
Rare Dis; 2016; 4(1):e1220468. PubMed ID: 28032012
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.
Chen HY; Bohlen JF; Maher BJ
Dev Neurosci; 2021; 43(3-4):159-167. PubMed ID: 34134113
[TBL] [Abstract][Full Text] [Related]
6. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
[TBL] [Abstract][Full Text] [Related]
7. Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription.
Sweatt JD
Exp Mol Med; 2013 May; 45(5):e21. PubMed ID: 23640545
[TBL] [Abstract][Full Text] [Related]
8. A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
Liu Y; Guo Y; Liu P; Li F; Yang C; Song J; Hu J; Xin D; Chen Z
Int J Dev Neurosci; 2018 Jun; 67():51-54. PubMed ID: 29604340
[TBL] [Abstract][Full Text] [Related]
9. Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of
Kim H; Gao EB; Draper A; Berens NC; Vihma H; Zhang X; Higashi-Howard A; Ritola KD; Simon JM; Kennedy AJ; Philpot BD
Elife; 2022 May; 11():. PubMed ID: 35535852
[TBL] [Abstract][Full Text] [Related]
10. The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria.
Marangi G; Ricciardi S; Orteschi D; Lattante S; Murdolo M; Dallapiccola B; Biscione C; Lecce R; Chiurazzi P; Romano C; Greco D; Pettinato R; Sorge G; Pantaleoni C; Alfei E; Toldo I; Magnani C; Bonanni P; Martinez F; Serra G; Battaglia D; Lettori D; Vasco G; Baroncini A; Daolio C; Zollino M
Am J Med Genet A; 2011 Jul; 155A(7):1536-45. PubMed ID: 21671391
[TBL] [Abstract][Full Text] [Related]
11. Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome.
Sparber P; Filatova A; Anisimova I; Markova T; Voinova V; Chuhrova A; Tabakov V; Skoblov M
Eur J Med Genet; 2020 Dec; 63(12):104088. PubMed ID: 33069932
[TBL] [Abstract][Full Text] [Related]
12. TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease.
Navarrete K; Pedroso I; De Jong S; Stefansson H; Steinberg S; Stefansson K; Ophoff RA; Schalkwyk LC; Collier DA
Am J Med Genet B Neuropsychiatr Genet; 2013 Jan; 162B(1):1-16. PubMed ID: 23129290
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.
Forrest M; Chapman RM; Doyle AM; Tinsley CL; Waite A; Blake DJ
Hum Mutat; 2012 Dec; 33(12):1676-86. PubMed ID: 22777675
[TBL] [Abstract][Full Text] [Related]
14. Pitt-Hopkins Mouse Model has Altered Particular Gastrointestinal Transits In Vivo.
Grubišić V; Kennedy AJ; Sweatt JD; Parpura V
Autism Res; 2015 Oct; 8(5):629-33. PubMed ID: 25728630
[TBL] [Abstract][Full Text] [Related]
15. A typical variant in TCF4 exon 18 is not associated with Pitt-Hopkins syndrome but with a familial case of mild and nonspecific neurodevelopmental disorder.
Aldeeri AA; Abu-El-Haija A
Am J Med Genet A; 2023 Apr; 191(4):1070-1076. PubMed ID: 36574749
[TBL] [Abstract][Full Text] [Related]
16. Pitt-Hopkins Syndrome.
Peippo M; Ignatius J
Mol Syndromol; 2012 Apr; 2(3-5):171-180. PubMed ID: 22670138
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation episignature and comparative epigenomic profiling for Pitt-Hopkins syndrome caused by TCF4 variants.
van der Laan L; Lauffer P; Rooney K; Silva A; Haghshenas S; Relator R; Levy MA; Trajkova S; Huisman SA; Bijlsma EK; Kleefstra T; van Bon BW; Baysal Ö; Zweier C; Palomares-Bralo M; Fischer J; Szakszon K; Faivre L; Piton A; Mesman S; Hochstenbach R; Elting MW; van Hagen JM; Plomp AS; Mannens MMAM; Alders M; van Haelst MM; Ferrero GB; Brusco A; Henneman P; Sweetser DA; Sadikovic B; Vitobello A; Menke LA
HGG Adv; 2024 Apr; 5(3):100289. PubMed ID: 38571311
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the expression pattern of the schizophrenia-risk and intellectual disability gene TCF4 in the developing and adult brain suggests a role in development and plasticity of cortical and hippocampal neurons.
Jung M; Häberle BM; Tschaikowsky T; Wittmann MT; Balta EA; Stadler VC; Zweier C; Dörfler A; Gloeckner CJ; Lie DC
Mol Autism; 2018; 9():20. PubMed ID: 29588831
[TBL] [Abstract][Full Text] [Related]
19. TCF4 Mutations Disrupt Synaptic Function Through Dysregulation of RIMBP2 in Patient-Derived Cortical Neurons.
Davis BA; Chen HY; Ye Z; Ostlund I; Tippani M; Das D; Sripathy SR; Wang Y; Martin JM; Shim G; Panchwagh NM; Moses RL; Farinelli F; Bohlen JF; Li M; Luikart BW; Jaffe AE; Maher BJ
Biol Psychiatry; 2024 Apr; 95(7):662-675. PubMed ID: 37573005
[TBL] [Abstract][Full Text] [Related]
20. WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene
Hennig KM; Fass DM; Zhao WN; Sheridan SD; Fu T; Erdin S; Stortchevoi A; Lucente D; Cody JD; Sweetser D; Gusella JF; Talkowski ME; Haggarty SJ
Mol Neuropsychiatry; 2017 Jul; 3(1):53-71. PubMed ID: 28879201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
